Visa card payments will allow cryptocurrency USD Coin – after Elon Musk opened Bitcoin pay

   2021-03-29 10:03

QIAGEN: NeuMoDx Multiplex Test Gets FDA Emergency Use Authorization To Differentiate COVID-19

Qiagen N.V. (QGEN) announced Monday that the U.S. Food and Drug Administration or FDA has granted Emergency Use Authorization for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test.

The polymerase chain reaction or PCR multiplex test will help healthcare professionals quickly identify and differentiate individuals suspected by a healthcare provider of respiratory viral infection consistent with COVID-19.



According to the company, the test will be an important tool now and in upcoming winter seasons for simultaneous qualitative detection and differentiation of influenzas A and B, respiratory syncytial virus or RSV and SARS-CoV-2 infections within 80 minutes.

The company projects growth in respiratory viral infections as restrictions are eased and social distancing measures are reduced. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2, influenza or RSV can be similar. This makes it essential to correctly identify them in order to treat and manage patients accordingly, especially in the COVID-19 pandemic.

QIAGEN launched the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test in the European Union and other markets that accept CE-IVD in November 2020. It will now begin commercialization of the test in the U.S.

Trio guilty of killing teenage boxer shot after car chase



Shih Tzu has ‘spine ripped apart’ by three dogs off their leads


Boris to address nation at 5pm as England takes next step out of lockdown


Return to freedom ‘at risk’ if people don’t follow lockdown rules

Woman, 37, charged with murder after newborn baby found dead in woods


Mini heatwave to bring 24C temperatures as BBQs with friends back on the cards




Russia’s RDIF signs deal to produce Sputnik V vaccine in China

FILE PHOTO: Bottles of Russia’s “Sputnik-V” COVID-19 vaccine are seen before inoculation at a clinic in Tver, Russia, October 12, 2020. REUTERS/Tatyana Makeyeva

MOSCOW (Reuters) – Russia’s RDIF sovereign wealth fund and China’s Shenzhen Yuanxing Gene-tech have agreed to produce over 60 million doses of Russia’s Sputnik V vaccine against COVID-19 in China, RDIF said on Monday.

RDIF, which is marketing Sputnik V globally, said that commercial production was due to start in May.

George Floyd’s sister breaks down in tears on GMB as Derek Chauvin faces trial




Czech billionaire Kellner killed in Alaska helicopter crash

Fox Business Flash top headlines for March 26

Fox Business Flash top headlines are here. Check out what’s clicking on FoxBusiness.com.

PRAGUE-The Czech Republic’s richest man, billionaire Petr Kellner, was killed in a helicopter crash in Alaska, his financial group PPF said on Monday. He was 56.

PPF said five people died in the crash, whose circumstances were being investigated.

“We announce with the deepest grief that, in a helicopter accident in Alaska mountains on Saturday, March 27, the founder and majority owner of the PPF group, Mr Petr Kellner, died tragically,” PPF said in a statement.

Kellner was a towering business figure of the Czech post-communist era, with his wealth estimated at $17.5 billion according to Forbes.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

His roots go back to the 1990s when he set up PPF as an investment company with partners to take part in the country’s scheme to privatize hundreds of state-owned companies.

PPF went on to grow in insurance, finance, telecommunications, manufacturing, media or biotech in businesses spanning mainly Europe, Asia and the United States.

Visa card payments will allow cryptocurrency USD Coin – after Elon Musk opened Bitcoin pay

When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.

The USD Coin will now be able to be used as a cryptocurrency, Visa announced today. Due to this, Visa has launched a pilot programme with platform, Crypto.com. The USD Coin is a cryptocurrency whose value is linked directly to the US dollar. 

Cuy Sheffield, head of crypto at Visa said: “We see increasing demand from consumers across the world to be able to access, hold and use digital currencies and we’re seeing demand from our clients to be able to build products that provide that access for consumers.”

This comes as Tesla announced it will allow the use of bitcoin to purchase of electric vehicles. 

Other firms such as Mastercard, Blackrock and BNY Mellon have allowed the use of cryptocurrencies. 

This a breaking news story, more to follow…


Original Source


CryptoCurrencyUSDChange 1hChange 24hChange 7d
Bitcoin61,560 0.29 % 2.70 % 6.02 %
Ethereum2,435.7 0.18 % 3.77 % 17.02 %
Binance Coin512.93 0.92 % 5.48 % 22.67 %
XRP1.600 1.66 % 9.29 % 52.50 %
Dogecoin0.3836 6.13 % 122.99 % 521.85 %
Tether0.9989 0.17 % 0.21 % 0.28 %
Cardano1.410 0.52 % 3.94 % 14.85 %
Polkadot41.65 0.97 % 4.61 % 0.59 %
Bitcoin Cash1,160.9 7.43 % 33.41 % 80.61 %
Litecoin312.08 1.16 % 8.02 % 37.83 %
Uniswap36.33 1.80 % 4.33 % 20.29 %
Chainlink42.16 0.52 % 0.97 % 28.77 %
VeChain0.2049 1.69 % 9.83 % 72.04 %
Stellar0.6075 0.36 % 5.71 % 20.90 %
Theta Network13.82 0.78 % 10.02 % 7.12 %
Filecoin183.14 0.75 % 6.95 % 18.33 %
USD Coin0.9991 0.07 % 0.03 % 0.23 %
TRON0.1631 0.11 % 2.72 % 31.65 %
Wrapped Bitcoin61,659 0.12 % 2.64 % 6.00 %
Bitcoin SV439.97 5.19 % 19.80 % 76.35 %